More Trouble at Big Pharma
243349
This lung cancer drug is not as effective as once hoped.
328935
SOME of the biggest companies in the drug industry are shivering under an avalanche of bad news. Merck has already been hit hard by the withdrawal of Vioxx, its arthritis drug.
203704
Investors are wary of putting money  into beaten-down generic-drug stocks amid continued fears of  price competition in the sector and new obstacles from  brand-name drug makers.
326050
UNDATED Another drug company is being accused of being too slow to pull a dangerous medication from the market. This time it&#39;s Baycol -- a cholesterol-lowering medicine that causes a severe and sometimes fatal muscle disorder in some patients.
130395
Critics charge conflict of interest in a system where pharmaceutical giants fund the regulatory process. By Alexandra Marks | Staff writer of The Christian Science Monitor.
63006
When Dr. Sherwin Siff got the news three months ago that the popular painkiller Vioxx was being pulled from the market, he had a good idea its cousins, Celebrex and Bextra, would face problems, too.
455403
The biopharma announces a dramatic shift following the failure of its lead drug.
566909
The FDA decides to debate the company's lead drug.
220042
The discontinuation of Exubera, an inhaled insulin, is another black eye for Pfizer, the worldâs biggest drug company, which has sustained a series of recent reversals.
603764
The pharmaceutical industry and Madison Avenue are increasingly concerned about their ability to continue to pitch prescription drugs at patients and doctors.
732193
* The world&#39;s biggest drug company loses $25 billion in market value in one day as investors fear another Vioxx debacle. NEW YORK - Pfizer Inc.
468234
ANOTHER week came to a close, but not on a happy note for a clutch of Indian drug companies which felt the heat for different reasons.
167282
The discontinuation of Exubera, an inhaled insulin, is another black eye for Pfizer, the worldâs biggest drug company, which has recently sustained a series of reversals.
149032
The stock is feeling some pain these days. However, this drugmaker has enough going for it that the illness shouldn&#39;t last. Amid nervousness over the future of Pfizer&#39;s arthritis pain treatment Celebrex and
1574
The food and drug administration, the pharmaceuticals regulator in the United States, was yesterday fighting to head off a crisis in confidence among the American public.
538571
The Wall Street Journal reports Merck &amp; Co. of Whitehouse Station, NJ, has begun hunting for a new chief executive officer. The move comes amid a string of bad news at the drug maker, including its recent
262080
There are two problems at the FDA. The first is that the Fraud and Drug Administration clearly puts the protection of Big Pharma profits as its primary mission, rather than protecting the public from dangerous drugs.